Analysis of Recent Papers in Hypertension.

Analyzes whether the Survival and Ventricular Enlargment trial with captopril study supports the recommendation by the American Heart Association Class I for the use of angiotensin converting enzyme (ACE)-inhibitor therapy in addition to other therapy immediately post-myocardial infarction once a patient is hemodynamically stable. Health benefits of ACE inhibitors; Possible outcome of combining an ACE inhibitor with an angiotensin receptor blocker; Aim of the Valsartan in Acute Myocardial Infarction trial.